Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial
Authors
Keywords
-
Journal
LANCET
Volume 400, Issue 10347, Pages 161-169
Publisher
Elsevier BV
Online
2022-06-29
DOI
10.1016/s0140-6736(22)01054-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Time to recognize three classes of non-inferiority trial margins
- (2022) Jeffrey L Saver et al. Journal of NeuroInterventional Surgery
- Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trial
- (2022) Andrew Bivard et al. LANCET NEUROLOGY
- Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial
- (2022) Christopher Elnan Kvistad et al. LANCET NEUROLOGY
- Ethical Justification for Deferral of Consent in the AcT Trial for Acute Ischemic Stroke
- (2022) Hannah Faris et al. STROKE
- Off-Label Use of Tenecteplase for the Treatment of Acute Ischemic Stroke
- (2022) Aristeidis H. Katsanos et al. JAMA Network Open
- Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke
- (2020) Bruce C. V. Campbell et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Provincial Door-to-Needle Improvement Initiative Results in Improved Patient Outcomes Across an Entire Population
- (2020) Noreen Kamal et al. STROKE
- Do Clinicians Overestimate the Severity of Intracerebral Hemorrhage?
- (2019) Elliot J. Tilling et al. STROKE
- Evidence that Tenecteplase Is Noninferior to Alteplase for Acute Ischemic Stroke
- (2019) Adrian M. Burgos et al. STROKE
- Canadian Stroke Best Practice Recommendations for Acute Stroke Management: Prehospital, Emergency Department, and Acute Inpatient Stroke Care, 6th Edition, Update 2018
- (2018) JM Boulanger et al. International Journal of Stroke
- Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke
- (2018) Bruce C.V. Campbell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial
- (2017) Nicola Logallo et al. LANCET NEUROLOGY
- Minimal Clinically Important Difference for Safe and Simple Novel Acute Ischemic Stroke Therapies
- (2017) Jessica S. Cranston et al. STROKE
- Minimal sufficient balance randomization for sequential randomized controlled trial designs: results from the ESCAPE trial
- (2017) Tolulope T. Sajobi et al. Trials
- Tenecteplase versus alteplase in stroke thrombolysis: An individual patient data meta-analysis of randomized controlled trials
- (2016) Xuya Huang et al. International Journal of Stroke
- Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study
- (2015) Xuya Huang et al. LANCET NEUROLOGY
- Tenecteplase–Tissue-Type Plasminogen Activator Evaluation for Minor Ischemic Stroke With Proven Occlusion
- (2015) Shelagh B. Coutts et al. STROKE
- The Heidelberg Bleeding Classification
- (2015) Rüdiger von Kummer et al. STROKE
- Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
- (2014) Jonathan Emberson et al. LANCET
- Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke
- (2013) Jeffrey L. Saver et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Randomized Trial of Tenecteplase versus Alteplase for Acute Ischemic Stroke
- (2012) Mark Parsons et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improving the Reliability of Stroke Disability Grading in Clinical Trials and Clinical Practice
- (2010) Jeffrey L. Saver et al. STROKE
- Phase IIB/III Trial of Tenecteplase in Acute Ischemic Stroke
- (2010) E. Clarke Haley et al. STROKE
- Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
- (2008) Werner Hacke et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started